Qifeng Chen
651 Dongfeng East Road
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Durvalumab plus HAIC-FOLFOX followed by maintenance durvalumab for hepatocellular carcinoma with major portal invasion: phase 2 DurHope study.
Journal: Nature communications
Published: June 24, 2025
Identification of candidates with hepatocellular carcinoma to receive TACE combined with MWA by assessing tumor burden and radiologic features.
Journal: Therapeutic advances in medical oncology
Published: November 09, 2024
Combining immune checkpoint inhibitors and molecular-targeted agents with hepatic arterial infusion chemotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus.
Journal: Hepatology international
Published: October 17, 2024
Survival path model outperforms conventional static machine learning models in long-term dynamic prognosis prediction for patients with intermediate stage hepatocellular carcinoma.
Journal: Bioinformatics advances
Published: July 26, 2024
Development of high barrier-coated white cardboard for fruit preservation.
Journal: RSC advances
Published: February 20, 2024
Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma.
Journal: Nature communications
Published: November 20, 2022
Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy.
Journal: Frontiers in oncology
Published: July 26, 2021
Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: May 23, 2021
Ferroptosis is involved in the progression of hepatocellular carcinoma through the circ0097009/miR-1261/SLC7A11 axis.
Journal: Annals of translational medicine
Published: May 14, 2021
Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?
Journal: Journal of hepatocellular carcinoma
Published: October 24, 2020
Transarterial chemoembolization combined with apatinib versus transarterial chemoembolization alone for hepatocellular carcinoma with macroscopic vascular invasion: A propensity score matching analysis.
Journal: Journal of cancer research and therapeutics
Published: October 02, 2020
Role of PRDM1 in Tumor Immunity and Drug Response: A Pan-Cancer Analysis.
Journal: Frontiers in pharmacology
Published: August 10, 2020
Last Updated: 09/26/2026